Perry Linz

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Boehringer Ingelheim Animal Health USA Inc., Merial Limited. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Perry Linz. Retrieved from https://idiyas.com/inventor/perry-linz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 14)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 20(Granted Patents)

Company Filing History:

4 out of 94

Boehringer Ingelheim Animal Health USA Inc.

Years Active: 2015-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12385068 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2025-08-12),

2. 11421249 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2022-08-23),

3. 10822620 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2020-11-03),

4. 10323257 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2019-06-18),

5. 9770502 - Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof (2017-09-26),

6. 9555096 - Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof (2017-01-31),

7. 9114108 - Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof (2015-08-25),

8. 9101598 - Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof (2015-08-11),

Title: The Innovative Contributions of Perry Linz

Introduction

Perry Linz is a notable inventor based in Jefferson, Georgia, who has made significant contributions to the field of veterinary medicine. With a total of eight patents to his name, Linz has focused on developing innovative solutions for avian health.

Latest Patents

Among his latest patents is the invention titled "Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof." This invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens. It includes compositions comprising the recombinant HVT vectors and polyvalent vaccines that utilize these vectors. Furthermore, the invention outlines methods of vaccination against various avian pathogens and the production of the recombinant HVT vectors.

Career Highlights

Throughout his career, Perry Linz has worked with prominent companies in the animal health sector, including Merial Limited and Boehringer Ingelheim Animal Health USA Inc. His work has significantly advanced the understanding and treatment of avian diseases.

Collaborations

Linz has collaborated with esteemed colleagues such as Michel Joseph Bublot and Teshome Mebatsion, contributing to the development of innovative veterinary solutions.

Conclusion

Perry Linz's contributions to veterinary medicine through his patents and collaborations highlight his commitment to improving avian health. His innovative work continues to impact the field positively.

Profile summary based on public USPTO records.